Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 May;82(1):289–294. doi: 10.1111/j.1476-5381.1984.tb16470.x

Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats.

B L Furman, K McKechnie, J R Parratt
PMCID: PMC1987265  PMID: 6375795

Abstract

The effects of two thromboxane synthetase inhibitors ( dazoxiben and UK 38485) were investigated on the cardiovascular and metabolic effects of Escherichia coli endotoxin infusion in the conscious, unrestrained rat. Infusion of E. coli endotoxin (41.7 ng kg-1 min-1) for 4 h produced a fall in mean arterial pressure, an increase in heart rate, a transient hyperglycaemia (at 1 h) followed by hypoglycaemia (evident at 6 h), an elevation in plasma lactate and a profound thrombocytopenia. The above changes were accompanied by a marked elevation in plasma thromboxane B2 concentrations (e.g. endotoxin-treated 935 +/- 150 pg ml-1 at 1 h compared with pre-endotoxin values of 125 +/- 30 pg ml-1). The administration of either dazoxiben (30 mg kg-1 i.v., given 30 min before starting the endotoxin infusion) or UK 38485 (15 mg kg-1 given 30 min before, and again 4 h after, starting the endotoxin infusion) prevented the rise in plasma thromboxane B2 concentrations. Neither dazoxiben nor UK 38485 prevented the metabolic, cardiovascular or thrombocytopenic effects of endotoxin and did not modify mortality. These results suggest that, although large amounts of thromboxane are generated in response to endotoxin, they do not play an important role in the major pathophysiological consequences of acute endotoxaemia.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adeleye G. A., Al-Jibouri L. M., Furman B. L., Parratt J. R. Exdotoxin-induced metabolic changes in the conscious, unrestrained rat: hypoglycemia and elevated blood lactate concentrations without hyperinsulinemia. Circ Shock. 1981;8(5):543–550. [PubMed] [Google Scholar]
  2. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  3. Ball H. A., Parratt J. R., Zeitlin I. J. Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anaesthetized cats. Br J Clin Pharmacol. 1983;15 (Suppl 1):127S–131S. doi: 10.1111/j.1365-2125.1983.tb02123.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown A. J., Casals-Stenzel J., Gofford S., Lever A. F., Morton J. J. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981 Sep;241(3):H381–H388. doi: 10.1152/ajpheart.1981.241.3.H381. [DOI] [PubMed] [Google Scholar]
  5. Cohen M. M., Greenway C. V., Innes I. R., Lister G. E., Murthy V. S., Scott G. D. Further observations on mesenteric vasoconstriction, survival and the clotting defect after endotoxin administration. Br J Pharmacol. 1973 Aug;48(4):555–569. doi: 10.1111/j.1476-5381.1973.tb08242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coker S. J., Clarke B., Zeitlin I. J. Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes. J Pharmacol Methods. 1982 May;7(3):207–217. doi: 10.1016/0160-5402(82)90037-7. [DOI] [PubMed] [Google Scholar]
  7. Coker S. J., Hughes B., Parratt J. R., Rodger I. W., Zeitlin I. J. The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol. 1983 Mar;78(3):561–570. doi: 10.1111/j.1476-5381.1983.tb08816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cook J. A., Wise W. C., Halushka P. V. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest. 1980 Jan;65(1):227–230. doi: 10.1172/JCI109655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fletcher J. R., Short B. L., Casey L. C., Walker R. I., Gardiner M., Ramwell P. W. Thromboxane inhibition in gram-negative sepsis fails to improve survival. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:117–120. [PubMed] [Google Scholar]
  10. Greenway C. V., Lautt W. W., Stark R. D. Separation of acute and delayed hemodynamic responses to endotoxin in the cat. Am J Physiol. 1969 Aug;217(2):518–521. doi: 10.1152/ajplegacy.1969.217.2.518. [DOI] [PubMed] [Google Scholar]
  11. Halushka P. V., Cook J. A., Wise W. C. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat. Br J Clin Pharmacol. 1983;15 (Suppl 1):133S–139S. doi: 10.1111/j.1365-2125.1983.tb02124.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Parratt J. R. Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol. 1973 Jan;47(1):12–25. doi: 10.1111/j.1476-5381.1973.tb08154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Samuelsson B., Goldyne M., Granström E., Hamberg M., Hammarström S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997–1029. doi: 10.1146/annurev.bi.47.070178.005025. [DOI] [PubMed] [Google Scholar]
  14. Wise W. C., Cook J. A., Halushka P. V., Knapp D. R. Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Circ Res. 1980 Jun;46(6):854–859. doi: 10.1161/01.res.46.6.854. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES